Wang Aifeng, Wang Yongping, Wang Guobao, Zhou Zhanmei, Yang Xiaobing
Department of Forensic Medicine, Southern Medical University, Guangzhou 510515, P.R. China.
Exp Ther Med. 2010 May;1(3):433-436. doi: 10.3892/etm_00000067. Epub 2010 May 1.
Infective endocarditis (IE) is a serious disease with a high associated mortality rate, particularly when complicated by acute renal failure (ARF). Although valve surgery and treatment with antibiotic agents are recommended, surgical options and the optimal therapy are not as yet well documented. Here, we report a rare case of IE in a young man with a history of intravenous drug abuse, who presented with high fever, bilateral thoracalgia, lower limb edema and renal dysfunction. After treatment with antibiotics, hemodialysis and anticoagulants, a tricuspid valve replacement surgery was performed on the patient. After surgery, his renal functions deteriorated and progressed to ARF. The first renal biopsy showed type II crescentic glomerulonephritis. After receiving continuous ambulatory peritoneal dialysis followed by administration of an angiotensin converting enzyme inhibitor and angiotensin receptor blockers, the patient's serum creatinine level decreased and the urine output increased gradually. In order to identify the renal turnover, we performed a second biopsy and found significant improvement in the pathological changes with endocapillary proliferative glomerulonephritis and fibrous crescents. Successful recovery of renal function was achieved 12 weeks after the initiation of therapy. Therefore, eradication of infection, tricuspid valve replacement and renal substitution therapy may be sufficient in some cases.
感染性心内膜炎(IE)是一种严重疾病,相关死亡率很高,尤其是并发急性肾衰竭(ARF)时。尽管推荐进行瓣膜手术和使用抗生素治疗,但手术选择和最佳治疗方法尚未有充分记录。在此,我们报告一例罕见的IE病例,患者为一名有静脉药物滥用史的年轻男性,表现为高热、双侧胸痛、下肢水肿和肾功能不全。在使用抗生素、血液透析和抗凝剂治疗后,对该患者实施了三尖瓣置换手术。术后,他的肾功能恶化并进展为ARF。首次肾活检显示为II型新月体性肾小球肾炎。在接受持续非卧床腹膜透析,随后给予血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂后,患者的血清肌酐水平下降,尿量逐渐增加。为了确定肾脏的转归,我们进行了第二次活检,发现病理改变有显著改善,表现为毛细血管内增生性肾小球肾炎和纤维性新月体。治疗开始12周后肾功能成功恢复。因此,在某些情况下,根除感染、三尖瓣置换和肾脏替代治疗可能就足够了。